E
EOS Imaging
EOS imaging, an ATEC company, is a leader in outcome-improving radiographic imaging and data-informed software solutions
About EOS Imaging
EOS imaging presents a compelling case in the medical imaging sector, specializing in orthopedic solutions. The company's core technology, which is based on the Nobel Prize-winning work of Georges Charpak, enables low-dose, full-body, 3D imaging of patients in a weight-bearing position. This system provides a comprehensive view of the musculoskeletal system, allowing for precise measurements and analysis of skeletal alignment, a critical factor in orthopedic diagnosis and surgical planning. The company was founded in 2004 by Marie Meynadier, who served as its CEO until 2019. Her background in physics and extensive experience in technology ventures were instrumental in translating a groundbreaking scientific discovery into a commercially viable medical device.
The business operates within the global orthopedic and medical imaging markets, targeting hospitals, orthopedic clinics, and radiology centers as its primary clients. Its revenue model is centered on the sale of its EOS imaging systems, coupled with recurring income from maintenance contracts and software solutions. The product portfolio includes the EOS and EOSedge systems, which are designed to capture high-quality images while significantly reducing the patient's exposure to radiation compared to traditional X-ray and CT scans. This is a particularly strong selling point for pediatric patients and individuals requiring frequent imaging. The company also offers a suite of software tools, such as 3D surgical planning services (EOSapps), which help surgeons prepare for complex procedures like spine, hip, and knee surgeries. In a significant milestone that reshaped its corporate structure, EOS imaging was acquired by Alphatec Holdings, Inc. (ATEC) in 2021, integrating its diagnostic capabilities with ATEC's portfolio of spinal surgery solutions.
This strategic acquisition aims to create a more comprehensive procedural workflow, from initial diagnosis and surgical planning with EOS technology to the execution of spinal fusion surgeries with ATEC's implants and instruments. The integration enhances the value proposition for surgeons by connecting pre-operative imaging and planning directly with intra-operative execution, thereby improving clinical outcomes. The company's journey from a physics-based concept to a key asset in a larger surgical technology corporation illustrates a successful trajectory of innovation and market adaptation in the healthcare industry. Its technology addresses the critical needs for safer imaging and more precise, data-driven surgical interventions in orthopedics.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1989
- Headquarters
- Paris, France
- Listing
- IPO 2012
- Employees
- 162
- Open positions
- 4
- Dealroom signal
- 87.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Patient Care, Radiology, Medical Imaging, Spinal Disease, biotech medtech and e-health, Observatoire Deeptech
- Technology
- Artificial Intelligence, Big Data, Deep Tech, Machine Learning, Computer Vision
- Client focus
- b2b
- Investment activity
- 1 company, latest Nov 2013
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Dec 2020 | $80M | $80M | Alphatec Spine | ↗ |
| LATE VC✓Equity / VC | Dec 2018 | $17M | $66M | Shanghai Fosun Pharmaceutical | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for EOS Imaging is 4.5K monthly website visits, up 9.8% over the last three months. EOS Imaging's team grew 22.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later7 investors entered at this stage
NBGI Ventures
Crédit Agricole
Andera Partners
UFG Asset Management
IPF Partners
Bpifrance
Shanghai Fosun Pharmaceutical
Other known investors6 additional known investors
Alphatec Spine
EOS Imaging
ACG Management
Agile Capital Markets
M Capital Partners
Omnes Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about EOS Imaging on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EOS Imaging’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







